Reportlinker finds all market research
reports published by official sources!

Investor presentation: Biopharmaceutical in The United States for Year 2011

  • This 22-page company report was published in March 2011.
... as well as 344 Biopharmaceutical industry reports, company profiles and country guides published by official sources (government, embassies, trade unions...).

Privacy Policy by TRUSTe

We value your privacy and will never rent or sell your email address. Privacy Policy by TRUSTe

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Talk to Sam

+1 917 267 7886

Share


Biopharmaceutical Industry in the United States : Latest Downloads

Intercell AG - Company Report for Year 2013

Intercell AG - Company Report for Year 2013

  • Company report
  • May 2013
  • 4 pages

... And production of rare, fully human monoclonal antibodies are offered by vivalis. Through these programs, vivalis receives payments associated with the funding of discovery research, an upfront payment, clinical ...

Pfizer Inc. - Company Report for Year 2012

Pfizer Inc. - Company Report for Year 2012

  • Company report
  • December 2012
  • 269 pages

... To as Follow-on biologics ). Such biosimilars would reference biotechnology products approved under the u.S. Public health service act. Additionally, the fda has approved a biosimilar recombinant human growth ...


Related Market Segments :

Vaccine
Cancer Vaccine
Antigen

Biopharmaceutical Industry in the United States : Latest Reports

Neugenesis Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Neugenesis Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2013
  • by Global Data

Summary Neugenesis Corporation (Neugenesis) is a privately held biotechnology company that is engaged in the development of technology platforms for the discovery and production of biotherapeutics. The ...

Repligen Corporation (RGEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Repligen Corporation (RGEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2013
  • by Global Data

Summary Repligen Corporation (Repligen) is a biopharmaceutical company indulged in discovery, development and commercialization of novel therapeutics in the areas of neurology and gastroenterology. The ...

RegeneRx Biopharmaceuticals, Inc. (RGRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

RegeneRx Biopharmaceuticals, Inc. (RGRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2013
  • by Global Data

Summary RegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is a biopharmaceutical company, based in the US. It provides research facilities for vaccine discovery for treatment of diseases ...


Related Market Segments :

Vaccine
Cancer Vaccine
Antigen
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.